Order Article Reprints

Zarif Attalla K, Hassan DH, Teaima MH, Yousry C, El-Nabarawi MA, Said MA, Elhabal SF. Enhanced Intranasal Delivery of Atorvastatin via Superparamagnetic Iron-Oxide-Loaded Nanocarriers: Cytotoxicity and Inflammation Evaluation and In Vivo, In Silico, and Network Pharmacology Study for Targeting Glioblastoma Management. Pharmaceuticals. 2025; 18(3):421. https://doi.org/10.3390/ph18030421

Zarif Attalla, Kristina, Doaa H. Hassan, Mahmoud H. Teaima, Carol Yousry, Mohamed A. El-Nabarawi, Mohamed A. Said, and Sammar Fathy Elhabal. 2025. "Enhanced Intranasal Delivery of Atorvastatin via Superparamagnetic Iron-Oxide-Loaded Nanocarriers: Cytotoxicity and Inflammation Evaluation and In Vivo, In Silico, and Network Pharmacology Study for Targeting Glioblastoma Management" Pharmaceuticals 18, no. 3: 421. https://doi.org/10.3390/ph18030421

Zarif Attalla, K., Hassan, D. H., Teaima, M. H., Yousry, C., El-Nabarawi, M. A., Said, M. A., & Elhabal, S. F. (2025). Enhanced Intranasal Delivery of Atorvastatin via Superparamagnetic Iron-Oxide-Loaded Nanocarriers: Cytotoxicity and Inflammation Evaluation and In Vivo, In Silico, and Network Pharmacology Study for Targeting Glioblastoma Management. Pharmaceuticals, 18(3), 421. https://doi.org/10.3390/ph18030421